Cargando…

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia

Detalles Bibliográficos
Autores principales:	Kim, Si-Ho, Kyu Cho, Hyun, Jeon, Chun-Hoo, Sung Ock, Hye, Shin, Beomsu, Wi, Yu Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420199/ https://www.ncbi.nlm.nih.gov/pubmed/36041645 http://dx.doi.org/10.1016/j.jinf.2022.08.016

Ejemplares similares

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia
por: Kattner, Simone, et al.
Publicado: (2023)

Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis
por: Bonella, Francesco, et al.
Publicado: (2013)

KL-6 levels in COVID-19
por: Scarpati, G, et al.
Publicado: (2020)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients
por: Determann, Rogier M, et al.
Publicado: (2010)

Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients
por: Maruyama, Shuhei, et al.
Publicado: (2022)

Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
por: Wang, Jingxian, et al.
Publicado: (2020)

Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis
por: Ohnishi, Hiroshi, et al.
Publicado: (2014)

KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022)

Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report
por: Yonenaga, Yoshikuni, et al.
Publicado: (2021)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
por: Bergantini, Laura, et al.
Publicado: (2019)

Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Specific Serum Markers of IPF: What Is the Significance of KL-6, SP-A, and SP-D?
por: Chiba, Hirofumi, et al.
Publicado: (2015)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
por: Jehn, Lutz B., et al.
Publicado: (2023)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
por: Mostafa, Amira Ismail, et al.
Publicado: (2021)

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
por: Lee, Jeong Seok, et al.
Publicado: (2019)

Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation
por: Berastegui, Cristina, et al.
Publicado: (2020)

Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2021)

Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients
por: Bocci, Silvia, et al.
Publicado: (2023)

BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6
por: Tobiume, Makoto, et al.
Publicado: (2014)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Establishing Sex-Dependent Reference Intervals for KL-6 in Danish Adults
por: Bruun, Stine Bakkensen, et al.
Publicado: (2023)

The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema
por: Chiba, Shigeki, et al.
Publicado: (2012)

Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease
por: Wei, Fengqin, et al.
Publicado: (2023)

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
por: Bonella, Francesco, et al.
Publicado: (2016)

Peritoneal Malignant Mesothelioma with Epithelioid Type, Demonstrating High Serum and Ascitic KL-6 Levels: Immunohistochemical Analyses
por: Nahar, Saifun, et al.
Publicado: (2015)

Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Matuszewski, Michal, et al.
Publicado: (2022)

High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19
por: Guirao, Jose J., et al.
Publicado: (2020)

Recombination Drives Evolution of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 KL47 to KL64 in China
por: Chen, Tao, et al.
Publicado: (2023)

The critical function of miR-1323/Il6 axis in children with Mycoplasma pneumoniae pneumonia
por: Yin, Linlin, et al.
Publicado: (2020)

Correlation of serum KL-6 and CC16 levels with neurodevelopmental outcome in premature infants at 12 months corrected age
por: Zhang, Zhiqun, et al.
Publicado: (2015)

The Serum Level of KL-6 Is Associated with the Risk of Insulin Resistance and New-onset Diabetes Mellitus: The Tanno-Sobetsu Study
por: Akasaka, Hiroshi, et al.
Publicado: (2017)

Digital Clubbing Is Associated with Higher Serum KL-6 Levels and Lower Pulmonary Function in Patients with Interstitial Lung Disease
por: Shiraishi, Kazushige, et al.
Publicado: (2018)

Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling
por: Suryananda, Titah Dhadhari, et al.
Publicado: (2021)

Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases
por: Tagami, Yoichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ugbbnlqtgam455h934ad43ec4